Xenon Pharmaceuticals announces public offering of 7.87M shares and pre-funded warrants for net proceeds of ~$234.6M

Xenon Pharmaceuticals Inc.

Offering of 7,868,854 common shares and pre-funded warrants for 327,868 shares at $30.50/share and $30.4999/warrant.
Net proceeds expected ~$234.6M after underwriting discounts and estimated expenses.
Underwriters granted 30-day option to purchase up to 1,229,508 additional common shares at $28.67/share.
Pre-funded warrants exercisable immediately at $0.0001 per share until exercised in full.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.